Global Cryptococcosis Market Size, Industry Trends, Share and Forecast 2021-2027
The global cryptococcosis market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market during the forecast period include the growing prevalence of cryptococcosis and the availability of advanced treatment. Cryptococcosis is a fungal infection which is caused by cryptococcus neoformans and Cryptococcus gattii which primarily affect the central nervous system and the lungs. People with diseases such as AIDS, Hodgkin lymphoma, other lymphomas, sarcoidosis, and solid organ transplantation with weakened immune systems are generally more susceptible to this type of infection. Cryptococcosis is usually acquired by inhalation of dust-containing yeast cells which typically affects the lungs.
To Request a Sample of our Report on Global
Cryptococcosis Market: https://www.omrglobal.com/request-sample/cryptococcosis-market
Cryptococcosis symptoms
include fever, malaise, cough, hemoptysis (bloody or blood-tinged sputum),
headache, vision changes (blurry or double vision, photophobia), and so on.
Cryptococcosis diagnosis is clinical and microscopic, which is confirmed by
culture or fixed-tissue staining. According to the United Nations Program on
HIV/AIDS and the World Health Organization (WHO), globally approximately one
million cases of cryptococcosis are reported each year resulting in 625,000
mortalities approximately. According to the Centers for Disease Control and
Prevention and WHO, it is estimated that globally every year 220,000 cases of
cryptococcal meningitis occur among people with HIV/AIDS, resulting in nearly
181,000 mortalities. However, adverse effects associated with the use of
medication is likely to restrain the market growth.
Cryptococcosis infects humans and animals, usually by
inhalation of the fungus, which results in lung infection that may spread to
the brain, causing meningoencephalitis. Flucytosine is a small, water-soluble
molecule that is a nucleoside analog antifungal drug that acts by disrupting
pyrimidine metabolism in the fungal cell nucleus. Flucytosine is generally
given as first-line treatment in combination with other antifungal medications.
Flucytosine was major revenue holding segment because it is given as a
first-line treatment in combination with other antifungal medications.
According to the United Nations Program on HIV/AIDS and the World Health
Organization, globally approximately one million cases of cryptococcosis are
reported each year resulting in 625,000 mortalities approximately. The
increasing prevalence of cryptococcosis and increasing new and advanced
treatment opportunities are the key factors that are boosting the growth of the
market during the forecast period.
(Get 15% Discount on Buying this Report)
A
full Report of Global Cryptococcosis Market is Available at: https://www.omrglobal.com/industry-reports/cryptococcosis-market
Global Cryptococcosis Market Report by Segment
·
By Treatment
·
Amphotericin B
·
Flucytosine
·
Fluconazole
·
Others
Global Cryptococcosis Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment